Overview

Detailed Summary

Mangalam Drugs and Organics Ltd is a chemical manufacturing company specializing in active pharmaceutical ingredients, perfumery, dye intermediates, and bulk drug intermediates. Established in 1972, its key facilities are located in Vapi and Sangamner.
The company has a strong manufacturing setup with significant production capacity expansions over the years, signaling its strategic focus on growth and scale in bulk drugs.
Mangalam has demonstrated a commitment to innovation by establishing an Intellectual Property Rights cell and securing WHO approvals for several active pharmaceutical ingredients since 2017.
The firm's extensive product portfolio includes chloroquine phosphate, aluminum chloride anhydrous, and other API intermediaries, positioning it as a versatile player in the pharma industry.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Market Cap: 46 Cr
Volatility: Moderate Risk
P/E Ratio: -1.5
Industry P/E: 27.5
PEG Ratio: —
P/B Ratio: 0.4
52W High: 94.80
52W Low: 22.70

Sales CAGR

1Y: -13.66%
3Y: -10.98%
5Y: 0.32%
10Y: 0.54%

Profit CAGR

1Y: 174.09%
3Y: -29.38%
5Y: -3.45%
10Y: -8.91%

ROE

TTM: -15.52%
3Y: -0.19%
5Y: 6.46%
10Y: 8.95%

ROCE

TTM: -2.61%
3Y: 6.96%
5Y: 13.99%
10Y: 17.80%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PHRMASI	81.86	56 Cr	3.15	8.60	0.00	7.28	7.84	40.10
MANGALAM	29.37	46 Cr	-1.50	0.39	0.00	-15.52	-2.61	-9.77
WALPAR	45.50	43 Cr	18.35	2.58	0.00	13.13	15.92	5.36
RAJNISH	0.41	42 Cr	-23.34	0.38	0.00	-0.10	0.05	-0.90
LASA	7.65	38 Cr	-0.87	0.68	0.00	0.87	-11.71	-61.75
VRL	120.00	38 Cr	10.03	0.98	1.67	11.58	14.72	7.89
WELCURE	0.30	37 Cr	0.72	0.28	0.00	25.60	17.53	5.59

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	97	102	77	80	89	73	57	50	58
Expenses	90	91	68	71	80	63	62	52	60
Operating Profit	6.98	12	8.20	8.70	8.77	10	-4.47	-2.84	-1.43
OPM %	7.17	11.44	10.71	10.88	9.89	13.91	-7.79	-5.73	-2.44
Other Income	0.00	0.05	0.02	0.14	0.14	0.21	0.00	0.03	0.11
Interest	3.31	3.95	3.75	3.67	3.49	4.03	4.04	5.03	4.05
Depreciation	3.63	3.86	3.88	3.97	4.05	4.70	4.48	4.63	4.46
Profit Before Tax	0.04	3.93	0.58	1.20	1.37	1.63	-13	-12	-9.84
Tax %	-1,150.00	10.18	-362.07	-124.17	5.84	96.93	-6.15	41.06	0.00
Net Profit	0.50	3.53	2.68	2.69	1.29	0.06	-14	-7.35	-9.84
EPS in Rs	0.31	2.23	1.70	1.70	0.81	0.04	-8.72	-4.64	-6.21

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025	TTM
Sales	369	318	299
Expenses	351	282	276
Operating Profit	17	36	23
OPM %	4.72	11.26	7.74
Other Income	0.10	0.50	NaN
Interest	14	15	15
Depreciation	15	17	17
Profit Before Tax	-11	4.79	-8.80
Tax %	18.08	-40.43	-10.91
Net Profit	-9.07	6.72	-9.76
EPS in Rs	—	4.25	-19.53
Dividend Payout %	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Equity Capital	16	16
Reserves	120	133
Borrowings	98	89
Other Liabilities	99	128
Total Liabilities	334	366
Fixed Assets	148	163
CWIP	7.74	2.69
Investments	0.00	0.00
Other Assets	178	201
Total Assets	334	366

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Cash from Operating Activity	3.91	43
Cash from Investing Activity	-12	-19
Cash from Financing Activity	5.23	-22
Net Cash Flow	-2.69	1.41

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	50.32%	50.32%	50.32%	50.32%	50.32%	50.32%	50.30%	50.30%	50.30%	50.30%	50.30%	35.64%
FIIs	0.10%	0.10%	0.10%	0.10%	0.26%	0.21%	0.11%	0.11%	0.46%	0.53%	0.11%	0.13%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	49.58%	49.58%	49.58%	49.58%	49.42%	49.47%	49.58%	49.58%	49.23%	49.16%	49.58%	64.22%
Total Shareholders	17,943	17,890	17,978	18,610	19,173	19,312	19,508	19,679	19,697	19,728	19,881	21,227

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q1 FY17

Investor Presentation

Q4 FY16

Investor Presentation

Q3 FY16

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd (MANGALAM) is currently trading at 30.83 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Mangalam Drugs and Organics Ltd is a chemical manufacturing company specializing in active pharmaceutical ingredients, perfumery, dye intermediates, and bulk drug intermediates. Established in 1972, its key facilities are located in Vapi and Sangamner. The company has a strong manufacturing setup with significant production capacity expansions over the years, signaling its strategic focus on growth and scale in bulk drugs. Mangalam has demonstrated a commitment to innovation by establishing an Intellectual Property Rights cell and securing WHO approvals for several active pharmaceutical ingredients since 2017. The firm's extensive product portfolio includes chloroquine phosphate, aluminum chloride anhydrous, and other API intermediaries, positioning it as a versatile player in the pharma industry.

Over the past 52 weeks, Mangalam Drugs and Organics Ltd has traded between a low of ₹22.70 and a high of ₹94.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Mangalam Drugs and Organics Ltd has a market capitalization of approximately 46.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Mangalam Drugs and Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1.50 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 46.49 Cr, Mangalam Drugs and Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Mangalam Drugs and Organics Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Mangalam Drugs and Organics Ltd is -1.50. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Mangalam Drugs And Organics Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Mangalam Drugs and Organics Ltd

What is Mangalam Drugs and Organics Ltd share price today?

What does Mangalam Drugs and Organics Ltd do?

What is the 52-week high and low of Mangalam Drugs and Organics Ltd?

What is the market capitalization of Mangalam Drugs and Organics Ltd?

Should I consider investing in Mangalam Drugs and Organics Ltd stock?

Is Mangalam Drugs and Organics Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Mangalam Drugs and Organics Ltd belong to and why does it matter?

What is the PE ratio of Mangalam Drugs and Organics Ltd?

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Mangalam Drugs and Organics Ltd

What is Mangalam Drugs and Organics Ltd share price today?

What does Mangalam Drugs and Organics Ltd do?

What is the 52-week high and low of Mangalam Drugs and Organics Ltd?

What is the market capitalization of Mangalam Drugs and Organics Ltd?

Should I consider investing in Mangalam Drugs and Organics Ltd stock?

Is Mangalam Drugs and Organics Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Mangalam Drugs and Organics Ltd belong to and why does it matter?

What is the PE ratio of Mangalam Drugs and Organics Ltd?

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Announcements

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist